Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	769-770
Number of pages	2
Journal	Diabetes and Metabolism Journal
Volume	47
Issue number	6
DOIs	https://doi.org/10.4093/dmj.2023.0351
Publication status	Published - Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{301fbc1cf11d4888a655a48de66b8f1a,

title = "Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin",

author = "Rhee, {Sang Youl}",

year = "2023",

month = nov,

doi = "10.4093/dmj.2023.0351",

language = "English",

volume = "47",

pages = "769--770",

journal = "Diabetes and Metabolism Journal",

issn = "2233-6079",

publisher = "Korean Diabetes Association",

number = "6",

}

TY - JOUR

T1 - Navigating the Future of Diabetes Treatment with New Drugs

T2 - Focusing on the Possibilities and Prospects of Enavogliflozin

AU - Rhee, Sang Youl

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85178649490&partnerID=8YFLogxK

U2 - 10.4093/dmj.2023.0351

DO - 10.4093/dmj.2023.0351

M3 - Editorial

C2 - 38043781

AN - SCOPUS:85178649490

SN - 2233-6079

VL - 47

SP - 769

EP - 770

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

IS - 6

ER -